Apomab: an agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors (Q94703959)
Jump to navigation
Jump to search
scientific article published in August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apomab: an agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors |
scientific article published in August 2008 |
Statements
Apomab: an agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors (English)